{"entity":{"type":"insider","cik":"0001355415","url":"/insider/0001355415","json_url":"/insider/0001355415.json","name":"Clark William D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":83,"n_filings":21,"first":"2006-11-08","last":"2025-01-13","span_basis":"filed_date"},"name_variants":[{"name":"Clark William D","source":"filing","n_filings":21,"first_seen":"2006-11-08","last_seen":"2025-01-13"}],"transactions":[{"id":5161886,"accession":"0001104659-25-003060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-003060","line_url":"/filing/0001104659-25-003060#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"iBio, Inc.","issuer_ticker":"IBIO","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1838.0,"shares_display":"1,838","price_per_share":2.72,"price_display":"2.72","price_state":"stated","total_value":4999.36,"total_display":"4,999.36","shares_owned_after":1838.0,"shares_owned_after_display":"1,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-10","filed_date":"2025-01-13","scope":"insider"},{"id":6949548,"accession":"0001457612-22-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-22-000073","line_url":"/filing/0001457612-22-000073#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4023.0,"shares_display":"4,023","price_per_share":0.06,"price_display":"0.06","price_state":"stated","total_value":241.38,"total_display":"241.38","shares_owned_after":304377.0,"shares_owned_after_display":"304,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider"},{"id":6223579,"accession":"0001457612-22-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-22-000069","line_url":"/filing/0001457612-22-000069#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117244.0,"shares_display":"117,244","price_per_share":0.0617,"price_display":"0.06","price_state":"stated","total_value":7233.9548,"total_display":"7,233.95","shares_owned_after":308400.0,"shares_owned_after_display":"308,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-02","scope":"insider"},{"id":6860446,"accession":"0001457612-22-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-22-000043","line_url":"/filing/0001457612-22-000043#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3924.0,"shares_display":"3,924","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":4905.0,"total_display":"4,905.00","shares_owned_after":369487.0,"shares_owned_after_display":"369,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-05","scope":"insider"},{"id":6483128,"accession":"0001457612-22-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001457612-22-000026","line_url":"/filing/0001457612-22-000026#line-2","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11435.0,"shares_display":"11,435","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":12578.5,"total_display":"12,578.50","shares_owned_after":373411.0,"shares_owned_after_display":"373,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-17","scope":"insider"},{"id":6758837,"accession":"0001457612-22-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001457612-22-000016","line_url":"/filing/0001457612-22-000016#line-2","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2080.0,"shares_display":"2,080","price_per_share":2.23,"price_display":"2.23","price_state":"stated","total_value":4638.4,"total_display":"4,638.40","shares_owned_after":286003.0,"shares_owned_after_display":"286,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2022-03-16","scope":"insider"},{"id":6758833,"accession":"0001457612-22-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-22-000016","line_url":"/filing/0001457612-22-000016#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3794.0,"shares_display":"3,794","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":10281.74,"total_display":"10,281.74","shares_owned_after":288083.0,"shares_owned_after_display":"288,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-02","filed_date":"2022-03-16","scope":"insider"},{"id":2813164,"accession":"0001457612-20-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-20-000176","line_url":"/filing/0001457612-20-000176#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4760.0,"shares_display":"4,760","price_per_share":2.06,"price_display":"2.06","price_state":"stated","total_value":9805.6,"total_display":"9,805.60","shares_owned_after":4760.0,"shares_owned_after_display":"4,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-10","scope":"insider"},{"id":6792020,"accession":"0001457612-18-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-18-000001","line_url":"/filing/0001457612-18-000001#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","shares_owned_after":82931.0,"shares_owned_after_display":"82,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-17","filed_date":"2018-01-19","scope":"insider"},{"id":3189335,"accession":"0001355415-16-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001355415-16-000004","line_url":"/filing/0001355415-16-000004#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2800.0,"shares_display":"2,800","price_per_share":3.49,"price_display":"3.49","price_state":"stated","total_value":9772.0,"total_display":"9,772.00","shares_owned_after":52205.0,"shares_owned_after_display":"52,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-07","filed_date":"2016-11-09","scope":"insider"},{"id":8623078,"accession":"0001457612-15-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-15-000024","line_url":"/filing/0001457612-15-000024#line-1","is_derivative":false,"issuer_cik":"0001355415","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001355415","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3800.0,"shares_display":"3,800","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":24510.0,"total_display":"24,510.00","shares_owned_after":43607.0,"shares_owned_after_display":"43,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-16","filed_date":"2015-12-16","scope":"insider"},{"id":7729600,"accession":"0001209191-10-011242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-011242","line_url":"/filing/0001209191-10-011242#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9522.0,"shares_display":"9,522","price_per_share":10.65,"price_display":"10.65","price_state":"stated","total_value":101409.3,"total_display":"101,409.30","shares_owned_after":168279.0,"shares_owned_after_display":"168,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-19","filed_date":"2010-02-23","scope":"insider"},{"id":5886903,"accession":"0001209191-09-057484","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-09-057484","line_url":"/filing/0001209191-09-057484#line-6","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":217749.0,"shares_display":"217,749","price_per_share":11.0514,"price_display":"11.05","price_state":"stated","total_value":2406431.2986,"total_display":"2,406,431.30","shares_owned_after":152801.0,"shares_owned_after_display":"152,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-14","filed_date":"2009-12-16","scope":"insider"},{"id":3509608,"accession":"0001209191-08-046453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-046453","line_url":"/filing/0001209191-08-046453#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":49500.0,"total_display":"49,500.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-07","filed_date":"2008-08-11","scope":"insider"},{"id":8380025,"accession":"0001209191-07-056791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-056791","line_url":"/filing/0001209191-07-056791#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":13.87,"price_display":"13.87","price_state":"stated","total_value":44384.0,"total_display":"44,384.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-01","filed_date":"2007-10-03","scope":"insider"},{"id":6966776,"accession":"0001209191-07-045778","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-07-045778","line_url":"/filing/0001209191-07-045778#line-8","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1065.0,"shares_display":"1,065","price_per_share":18.81,"price_display":"18.81","price_state":"stated","total_value":20032.65,"total_display":"20,032.65","shares_owned_after":2135.0,"shares_owned_after_display":"2,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":6966773,"accession":"0001209191-07-045778","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-07-045778","line_url":"/filing/0001209191-07-045778#line-7","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":835.0,"shares_display":"835","price_per_share":18.87,"price_display":"18.87","price_state":"stated","total_value":15756.45,"total_display":"15,756.45","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":6966771,"accession":"0001209191-07-045778","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-07-045778","line_url":"/filing/0001209191-07-045778#line-6","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.86,"price_display":"18.86","price_state":"stated","total_value":5658.0,"total_display":"5,658.00","shares_owned_after":835.0,"shares_owned_after_display":"835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":6966767,"accession":"0001209191-07-045778","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-07-045778","line_url":"/filing/0001209191-07-045778#line-5","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.85,"price_display":"18.85","price_state":"stated","total_value":5655.0,"total_display":"5,655.00","shares_owned_after":1135.0,"shares_owned_after_display":"1,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":6966765,"accession":"0001209191-07-045778","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-045778","line_url":"/filing/0001209191-07-045778#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":18.82,"price_display":"18.82","price_state":"stated","total_value":5646.0,"total_display":"5,646.00","shares_owned_after":1835.0,"shares_owned_after_display":"1,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":6966761,"accession":"0001209191-07-045778","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-045778","line_url":"/filing/0001209191-07-045778#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":18.84,"price_display":"18.84","price_state":"stated","total_value":3768.0,"total_display":"3,768.00","shares_owned_after":1435.0,"shares_owned_after_display":"1,435","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":6966758,"accession":"0001209191-07-045778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-045778","line_url":"/filing/0001209191-07-045778#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":18.83,"price_display":"18.83","price_state":"stated","total_value":3766.0,"total_display":"3,766.00","shares_owned_after":1635.0,"shares_owned_after_display":"1,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-01","filed_date":"2007-08-03","scope":"insider"},{"id":7618432,"accession":"0001209191-07-034974","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-15","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1120.0,"shares_display":"1,120","price_per_share":20.12,"price_display":"20.12","price_state":"stated","total_value":22534.4,"total_display":"22,534.40","shares_owned_after":586.0,"shares_owned_after_display":"586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618431,"accession":"0001209191-07-034974","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-14","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":20.07,"price_display":"20.07","price_state":"stated","total_value":10035.0,"total_display":"10,035.00","shares_owned_after":2006.0,"shares_owned_after_display":"2,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618430,"accession":"0001209191-07-034974","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-13","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.1,"price_display":"20.10","price_state":"stated","total_value":4020.0,"total_display":"4,020.00","shares_owned_after":1806.0,"shares_owned_after_display":"1,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618429,"accession":"0001209191-07-034974","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-12","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.05,"price_display":"20.05","price_state":"stated","total_value":4010.0,"total_display":"4,010.00","shares_owned_after":2706.0,"shares_owned_after_display":"2,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618428,"accession":"0001209191-07-034974","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-11","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.05,"price_display":"20.05","price_state":"stated","total_value":4010.0,"total_display":"4,010.00","shares_owned_after":2506.0,"shares_owned_after_display":"2,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618427,"accession":"0001209191-07-034974","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-10","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":194.0,"shares_display":"194","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":3881.94,"total_display":"3,881.94","shares_owned_after":3006.0,"shares_owned_after_display":"3,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618426,"accession":"0001209191-07-034974","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-9","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":174.0,"shares_display":"174","price_per_share":20.23,"price_display":"20.23","price_state":"stated","total_value":3520.02,"total_display":"3,520.02","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618425,"accession":"0001209191-07-034974","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-8","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.24,"price_display":"20.24","price_state":"stated","total_value":2024.0,"total_display":"2,024.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618424,"accession":"0001209191-07-034974","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-7","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.21,"price_display":"20.21","price_state":"stated","total_value":2021.0,"total_display":"2,021.00","shares_owned_after":286.0,"shares_owned_after_display":"286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618423,"accession":"0001209191-07-034974","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-6","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.19,"price_display":"20.19","price_state":"stated","total_value":2019.0,"total_display":"2,019.00","shares_owned_after":386.0,"shares_owned_after_display":"386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618422,"accession":"0001209191-07-034974","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-5","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.17,"price_display":"20.17","price_state":"stated","total_value":2017.0,"total_display":"2,017.00","shares_owned_after":486.0,"shares_owned_after_display":"486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618420,"accession":"0001209191-07-034974","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.11,"price_display":"20.11","price_state":"stated","total_value":2011.0,"total_display":"2,011.00","shares_owned_after":1706.0,"shares_owned_after_display":"1,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618419,"accession":"0001209191-07-034974","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.02,"price_display":"20.02","price_state":"stated","total_value":2002.0,"total_display":"2,002.00","shares_owned_after":2906.0,"shares_owned_after_display":"2,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7618418,"accession":"0001209191-07-034974","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-034974","line_url":"/filing/0001209191-07-034974#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12.0,"shares_display":"12","price_per_share":20.22,"price_display":"20.22","price_state":"stated","total_value":242.64,"total_display":"242.64","shares_owned_after":274.0,"shares_owned_after_display":"274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-06-01","filed_date":"2007-06-04","scope":"insider"},{"id":7848199,"accession":"0001209191-07-021788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-021788","line_url":"/filing/0001209191-07-021788#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":24.13,"price_display":"24.13","price_state":"stated","total_value":77216.0,"total_display":"77,216.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-02","filed_date":"2007-04-03","scope":"insider"},{"id":6992530,"accession":"0001209191-07-006781","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-15","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":901.0,"shares_display":"901","price_per_share":29.5,"price_display":"29.50","price_state":"stated","total_value":26579.5,"total_display":"26,579.50","shares_owned_after":599.0,"shares_owned_after_display":"599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992528,"accession":"0001209191-07-006781","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-14","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":599.0,"shares_display":"599","price_per_share":29.42,"price_display":"29.42","price_state":"stated","total_value":17622.58,"total_display":"17,622.58","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992523,"accession":"0001209191-07-006781","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-13","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":29.52,"price_display":"29.52","price_state":"stated","total_value":14760.0,"total_display":"14,760.00","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992521,"accession":"0001209191-07-006781","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-12","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":29.5,"price_display":"29.50","price_state":"stated","total_value":5900.0,"total_display":"5,900.00","shares_owned_after":1600.0,"shares_owned_after_display":"1,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992518,"accession":"0001209191-07-006781","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-11","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.8,"price_display":"29.80","price_state":"stated","total_value":2980.0,"total_display":"2,980.00","shares_owned_after":2700.0,"shares_owned_after_display":"2,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992512,"accession":"0001209191-07-006781","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-10","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.68,"price_display":"29.68","price_state":"stated","total_value":2968.0,"total_display":"2,968.00","shares_owned_after":2900.0,"shares_owned_after_display":"2,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992509,"accession":"0001209191-07-006781","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-9","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.67,"price_display":"29.67","price_state":"stated","total_value":2967.0,"total_display":"2,967.00","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992506,"accession":"0001209191-07-006781","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-8","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.65,"price_display":"29.65","price_state":"stated","total_value":2965.0,"total_display":"2,965.00","shares_owned_after":2600.0,"shares_owned_after_display":"2,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992503,"accession":"0001209191-07-006781","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-7","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.63,"price_display":"29.63","price_state":"stated","total_value":2963.0,"total_display":"2,963.00","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992500,"accession":"0001209191-07-006781","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-6","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.56,"price_display":"29.56","price_state":"stated","total_value":2956.0,"total_display":"2,956.00","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992497,"accession":"0001209191-07-006781","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-5","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.54,"price_display":"29.54","price_state":"stated","total_value":2954.0,"total_display":"2,954.00","shares_owned_after":3100.0,"shares_owned_after_display":"3,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992494,"accession":"0001209191-07-006781","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.48,"price_display":"29.48","price_state":"stated","total_value":2948.0,"total_display":"2,948.00","shares_owned_after":1800.0,"shares_owned_after_display":"1,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"},{"id":6992491,"accession":"0001209191-07-006781","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-006781","line_url":"/filing/0001209191-07-006781#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001355415","owner_name":"Clark William D","owner_url":"/insider/0001355415","role":"Officer (Sr. VP, Chief Business Officer)","officer_title":"Sr. VP, Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":29.44,"price_display":"29.44","price_state":"stated","total_value":2944.0,"total_display":"2,944.00","shares_owned_after":1900.0,"shares_owned_after_display":"1,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-01","filed_date":"2007-02-01","scope":"insider"}],"next_cursor":"2007-02-01|6992491","ledger_fault":false,"count":{"value":83,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":77,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":83},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001420720","name":"iBio, Inc.","url":"/issuer/0001420720","role":"Director","n_filings":1,"first_seen":"2025-01-13","last_seen":"2025-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001457612","name":"GENOCEA BIOSCIENCES, INC.","url":"/issuer/0001457612","role":"Director, Officer (President and CEO)","n_filings":9,"first_seen":"2015-12-16","last_seen":"2022-06-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (Sr. VP, Chief Business Officer)","n_filings":11,"first_seen":"2006-11-08","last_seen":"2010-02-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001355415","retrieved_at":"2026-08-21T18:29:54+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}